Why the study?
Does oral anticoagulation improve clinical outcomes in patients with heart failure in sinus rhythm?
Population
Patients with heart failure in sinus rhythm (without atrial fibrillation)
Design
Review
Authors
Loading...
Does not support routine OAC use in HF sinus rhythm; leaves open whether selected high-risk subgroups warrant prospective trials.
Does oral anticoagulation improve clinical outcomes in patients with heart failure in sinus rhythm?
Current evidence does not support the routine use of oral anticoagulants in heart failure patients in sinus rhythm due to major bleeding risks outweighing thromboembolic benefits.
Siliste et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: